US 8796270
N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor
granted A61KA61K9/0053A61P
Quick answer
US patent 8796270 (N-[6-(1H-indazol-6-yl)imidazo[1,2-A]pyridin-8-yl]-6-(morpholin-4-yl)pyridazin-3-amine, or a pharmaceutically acceptable salt thereof, as a SYK inhibitor) held by GILEAD CONNECTICUT, INC. expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- GILEAD CONNECTICUT, INC.
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61K, A61K9/0053, A61P, A61P1/00, A61P11/00